Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.
Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside.
It's having trouble getting its core business model to work.
Not all of my investments have been winners. Here are three that went badly and the important lessons I learned from them.
New York, New York--(Newsfile Corp. - December 7, 2023) - 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ: ME), recently suffered a massive...
USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully...
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END
Both businesses have a lot to prove.
Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...